These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6268719)

  • 41. Characterization of a continuous cell line in culture established from a Krukenberg tumour of the ovary arising from a primary gastric adenocarcinoma.
    Whelan R; Gibby E; Sheer D; Povey S; Hill BT
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1397-408. PubMed ID: 2846312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro culture of human cancer cells for cancer chemotherapy. II. In vitro drug sensitivity of cultured suspended cell line of gastric carcinoma origin.
    Oboshi S; Seido T
    Gan; 1969 Apr; 60(2):231-6. PubMed ID: 4309389
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cell kinetic study on the effects of cancer chemotherapeutic agents on primary culture cells from human oral mucosa (author's transl)].
    Yamamoto E
    Kokubyo Gakkai Zasshi; 1974 Sep; 41(3):260-85. PubMed ID: 4140210
    [No Abstract]   [Full Text] [Related]  

  • 44. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models.
    Adams KM; Wendt JR; Wood J; Olson S; Moreno R; Jin Z; Gopalan S; Lang JD
    bioRxiv; 2024 Jul; ():. PubMed ID: 39131380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis.
    Pavlič R; Gjorgoska M; Rižner TL
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine.
    Yee C; Dickson KA; Muntasir MN; Ma Y; Marsh DJ
    Front Bioeng Biotechnol; 2022; 10():836984. PubMed ID: 35223797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy.
    Wong-Brown MW; van der Westhuizen A; Bowden NA
    BMC Cancer; 2022 Jan; 22(1):100. PubMed ID: 35073851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.
    Poschner S; Wackerlig J; Castillo-Tong DC; Wolf A; Decken IV; Rižner TL; Pavlič R; Meshcheryakova A; Mechtcheriakova D; Fritzer-Szekeres M; Thalhammer T; Jäger W
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
    Kotrbová A; Ovesná P; Gybel' T; Radaszkiewicz T; Bednaříková M; Hausnerová J; Jandáková E; Minář L; Crha I; Weinberger V; Záveský L; Bryja V; Pospíchalová V
    Theranostics; 2020; 10(2):537-552. PubMed ID: 31903136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.
    Papp E; Hallberg D; Konecny GE; Bruhm DC; Adleff V; Noë M; Kagiampakis I; Palsgrove D; Conklin D; Kinose Y; White JR; Press MF; Drapkin R; Easwaran H; Baylin SB; Slamon D; Velculescu VE; Scharpf RB
    Cell Rep; 2018 Nov; 25(9):2617-2633. PubMed ID: 30485824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating cell lines as tumour models by comparison of genomic profiles.
    Domcke S; Sinha R; Levine DA; Sander C; Schultz N
    Nat Commun; 2013; 4():2126. PubMed ID: 23839242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
    Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quantitative analysis on in vitro drug sensitivity of cultured human ovarian cancer cell lines (author's transl)].
    Motoyama T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):308-14. PubMed ID: 7069245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A newly established cel line derived from human ovarian adenocarcinoma.
    Sekiguchi M; Sakakibara K; Suzuki T; Motoyama T; Fujii G
    Jpn J Exp Med; 1980 Aug; 50(4):283-92. PubMed ID: 7441907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment of cultured cell lines derived from a human gastric carcinoma.
    Sekiguchi M; Sakakibara K; Fujii G
    Jpn J Exp Med; 1978 Feb; 48(1):61-8. PubMed ID: 209229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of anticancer drugs on in vitro survival of cell lines derived from various gynecologic tumors (author's transl)].
    Sekiya S; Takamizawa H
    Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):373-6. PubMed ID: 6163305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Human cancer cell lines in Japan (author's transl)].
    Oboshi S; Sekiguchi M
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):697-711. PubMed ID: 358290
    [No Abstract]   [Full Text] [Related]  

  • 58. [Biological characterization including sensitivity to mitomycin C of cultured human ovarian cancers (author's transl)].
    Motoyama T
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1197-204. PubMed ID: 6268719
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.